Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

1-Minute Earnings Review: JPMorgan Chase & Co (JPM)

JPMorgan Chase & Co. (NYSE:JPM) has released earnings, but at the forefront of everyone’s mind is the London Whale scandal. While this did cause CEO Jamie Dimon to lose $10 million, which is half his pay, that’s a drop in the bucket for this international bank. Also, the additional losses of transferring the portfolio involved in the Whale’s trades onto JPMorgan’s books were minor. In this video, Motley Fool financial analyst Matt Koppenheffer moves on to discuss the actual earnings report and tells us all the ways that the numbers look good.

JPMorgan Chase & Co (NYSE:JPM)

With big finance firms still trading at deep discounts to their historic norms, investors everywhere are wondering if this is the new normal, or whether finance stocks are a screaming buy today. The answer depends on the company, so to help figure out whether JPMorgan is a buy today, I invite you to read our premium research report on the company today. Click here now for instant access!

The article 1-Minute Earnings Review: JPMorgan Chase originally appeared on

Fool contributor Matt Koppenheffer has no position in any stocks mentioned. The Motley Fool owns shares of JPMorgan Chase.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!